These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Prognostic implication of valvular lesion and left ventricular size in asymptomatic patients with chronic organic mitral regurgitation and normal left ventricular performance. Krauss J, Pizarro R, Oberti PF, Falconi M, Cagide A. Am Heart J; 2006 Nov 01; 152(5):1004.e1-8. PubMed ID: 17070180 [Abstract] [Full Text] [Related]
5. Alcohol consumption and prognosis in patients with left ventricular systolic dysfunction after a myocardial infarction. Aguilar D, Skali H, Moyé LA, Lewis EF, Gaziano JM, Rutherford JD, Hartley LH, Randall OS, Geltman EM, Lamas GA, Rouleau JL, Pfeffer MA, Solomon SD. J Am Coll Cardiol; 2004 Jun 02; 43(11):2015-21. PubMed ID: 15172406 [Abstract] [Full Text] [Related]
6. Prevalence, clinical characteristics, quality of life, and prognosis of patients with congestive heart failure and isolated left ventricular diastolic dysfunction. Badano LP, Albanese MC, De Biaggio P, Rozbowsky P, Miani D, Fresco C, Fioretti PM. J Am Soc Echocardiogr; 2004 Mar 02; 17(3):253-61. PubMed ID: 14981424 [Abstract] [Full Text] [Related]
7. Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and/or left ventricular dysfunction: a VALIANT study. Lewis EF, Velazquez EJ, Solomon SD, Hellkamp AS, McMurray JJ, Mathias J, Rouleau JL, Maggioni AP, Swedberg K, Kober L, White H, Dalby AJ, Francis GS, Zannad F, Califf RM, Pfeffer MA. Eur Heart J; 2008 Mar 02; 29(6):748-56. PubMed ID: 18308687 [Abstract] [Full Text] [Related]
8. Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction. Solomon SD, Skali H, Anavekar NS, Bourgoun M, Barvik S, Ghali JK, Warnica JW, Khrakovskaya M, Arnold JM, Schwartz Y, Velazquez EJ, Califf RM, McMurray JV, Pfeffer MA. Circulation; 2005 Jun 28; 111(25):3411-9. PubMed ID: 15967846 [Abstract] [Full Text] [Related]
9. Effect of primary mitral regurgitation on left ventricular synchrony. Denney TS, Nagaraj HM, Lloyd SG, Aban I, Corros C, Seghatol-Eslami F, McGiffin DC, Dell'Italia LJ, Gupta H. Am J Cardiol; 2007 Aug 15; 100(4):707-11. PubMed ID: 17697833 [Abstract] [Full Text] [Related]
11. Heart failure and death after myocardial infarction in the community: the emerging role of mitral regurgitation. Bursi F, Enriquez-Sarano M, Nkomo VT, Jacobsen SJ, Weston SA, Meverden RA, Roger VL. Circulation; 2005 Jan 25; 111(3):295-301. PubMed ID: 15655133 [Abstract] [Full Text] [Related]
13. [Prognostic significance of typical immune reactions in myocardial infarction]. Zemskov AM, Alekhina OD, Zemskov VM, Zemskov MA, Zoloedov VI. Ter Arkh; 2008 Jul 04; 80(1):32-7. PubMed ID: 18326224 [Abstract] [Full Text] [Related]
14. Ischemic mitral valve repair: predictive significance of restrictive left ventricular diastolic filling. Ereminiene E, Vaskelyte J, Benetis R, Stoskute N. Echocardiography; 2005 Mar 04; 22(3):217-24. PubMed ID: 15725156 [Abstract] [Full Text] [Related]
15. Usefulness of left ventricular diastolic dysfunction as a predictor of one-year rehospitalization in survivors of acute myocardial infarction. Khumri TM, Reid KJ, Kosiborod M, Spertus JA, Main ML. Am J Cardiol; 2009 Jan 01; 103(1):17-21. PubMed ID: 19101223 [Abstract] [Full Text] [Related]
16. Early and late effects of cardiac resynchronization therapy on exercise-induced mitral regurgitation: relationship with left ventricular dyssynchrony, remodelling and cardiopulmonary performance. Madaric J, Vanderheyden M, Van Laethem C, Verhamme K, Feys A, Goethals M, Verstreken S, Geelen P, Penicka M, De Bruyne B, Bartunek J. Eur Heart J; 2007 Sep 01; 28(17):2134-41. PubMed ID: 17504802 [Abstract] [Full Text] [Related]
17. The relationship between mitral regurgitation and ejection fraction as predictors for the prognosis of patients with heart failure. Pecini R, Thune JJ, Torp-Pedersen C, Hassager C, Køber L. Eur J Heart Fail; 2011 Oct 01; 13(10):1121-5. PubMed ID: 21865237 [Abstract] [Full Text] [Related]
18. Long-term effect of cardiac resynchronization therapy on functional mitral valve regurgitation. Sitges M, Vidal B, Delgado V, Mont L, Garcia-Alvarez A, Tolosana JM, Castel A, Berruezo A, Azqueta M, Pare C, Brugada J. Am J Cardiol; 2009 Aug 01; 104(3):383-8. PubMed ID: 19616672 [Abstract] [Full Text] [Related]
19. Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. Wu AH, Aaronson KD, Bolling SF, Pagani FD, Welch K, Koelling TM. J Am Coll Cardiol; 2005 Feb 01; 45(3):381-7. PubMed ID: 15680716 [Abstract] [Full Text] [Related]
20. Predictors of mortality from pump failure and sudden cardiac death in patients with systolic heart failure and left ventricular dyssynchrony: results of the CARE-HF trial. Uretsky BF, Thygesen K, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L, Cleland JG. J Card Fail; 2008 Oct 01; 14(8):670-5. PubMed ID: 18926439 [Abstract] [Full Text] [Related] Page: [Next] [New Search]